Showing results (691-700 of 841) with videos related to
Sort By:
Pageof 85
Leukemia & Lymphoma|January 1, 1993
Is recombinant human erythropoietin treatment in myelodysplastic syndromes worthwhile?M A Aloe Spiriti, M C Petti, R Latagliata, et al.Transplant Immunology|March 12, 2022
De novo human leukocyte antigen allosensitization patterns in patients bridged to heart transplantation using left ventricular assist devicesVinh Q Chau, Jason Feinman, Kerianne Fullin, et al.Journal of Medical Genetics|June 30, 2000
A new simple enzyme assay for pre- and postnatal diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) and its variantsY V Voznyi, J L Keulemans, G M Mancini, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 31, 2012
Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring systemJonathan A Yang, Tomoko S Kato, Brittney P Shulman, et al.Haematologica|March 1, 1993
Recombinant human erythropoietin in the treatment of myelodysplastic syndromes. An interim reportM A Aloe Spiriti, M C Petti, R Latagliata, et al.International Journal of Immunopathology and Pharmacology|October 14, 2009
Bromhidrosis induced by sphingomonas paucimobilis: a case reportM Mancini, V Panasiti, V Devirgiliis, et al.The American Journal of Clinical Nutrition|November 1, 1984
Changing the Mediterranean diet: effects on blood lipidsA Ferro-Luzzi, P Strazzullo, C Scaccini, et al.Journal of Cardiac Failure|December 29, 2023
Frequency and Clinical Implications of Referrals to Heart Failure Among Patients with Peripartum CardiomyopathyNatasha Qureshi, Amy Kontorovich, Emir Veledar, et al.American Journal of Human Genetics|January 3, 2012
COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic strokeMarion Jeanne, Cassandre Labelle-Dumais, Jeff Jorgensen, et al.Leukemia|April 1, 1996
Clinical and cytologic characteristics of blastic phase in Ph-positive chronic myeloid leukemia treated with alpha-interferonG Alimena, M Lazzarino, E Morra, et al.Pageof 85